4.5 Miscellaneous drugs

Dr. Swathi Acharya Associate professor, Dept. of Pharmacology, KSHEMA
11 Mar 202207:40

Summary

TLDRThis educational module delves into various anti-epileptic drugs, focusing on their mechanisms of action and classifications. It covers sodium channel blockers like zonisamide, phenobarbital, and lacosamide, each with unique side effects. Potassium channel openers, NMDA and AMPA antagonists, and synaptic vascular protein inhibitors are also discussed, highlighting their specific uses and potential adverse effects. Notably, lamotrigine carries a black box warning due to suicidal tendencies, while levetiracetam is favored for its efficacy and safety in pregnant women. The module concludes with a look ahead to future discussions on epilepsy first aid and management.

Takeaways

  • 💊 The module covers miscellaneous anti-epileptic drugs, which are classified based on their mechanisms of action.
  • 🔬 Sodium channel blockers are a subclass of drugs, including newer drugs like zonisamide, which has multiple mechanisms including carbonic anhydrase inhibition.
  • 🌟 Xenosamide is used for refractory partial seizures and can cause dose-related adverse effects like dizziness and headache.
  • 🧬 Aurophinamide is a sodium channel blocker used in epilepsy syndromes, with no drug interactions due to lack of metabolism by microorganismal enzymes.
  • 💧 Lacosamide has a dual mechanism of action, inhibiting sodium channels and collapsing receptor-mediated protein, used for partial seizures with dose-related side effects.
  • 🔋 Potassium channel openers, like retigabine, prolong after hyperpolarization to reduce neuronal excitability, used for resistant partial seizures with unique side effects.
  • 💥 NMDA antagonists, such as felbamate, block NMDA receptors and voltage-gated calcium channels, used for generalized seizures but can cause serious side effects like marrow suppression.
  • 🚫 AMPA antagonists, like perampanel, are used for partial seizures and have side effects like weight gain and dizziness.
  • 🧠 Levetiracetam modulates synaptic vesicle protein to balance excitatory and inhibitory neurotransmitters, used for various seizure types with fewer side effects.
  • 🤰 Levetiracetam is a preferred drug in epilepsy during pregnancy due to its efficacy and safety, available in different strengths for dosage adjustment.

Q & A

  • What are the main groups of anti-epileptic drugs discussed in the module?

    -The main groups of anti-epileptic drugs discussed include sodium channel blockers, potassium channel openers, NMDA antagonists, AMPA antagonists, and synaptic vascular protein inhibitors.

  • What is the primary mechanism of action of the newer sodium channel blockers like solid graphene glucosamine?

    -Solid graphene glucosamine acts primarily by blocking voltage-dependent sodium channels, inhibiting certain types of calcium channels, and causing carbonic anhydrase inhibition.

  • What are the adverse effects associated with solid graphene glucosamine?

    -Adverse effects of solid graphene glucosamine include dizziness, headache, irritability, anorexia, metabolic acidosis, nephrolithiasis, and hypohydrosis, mainly due to its carbonic anhydrase property.

  • How does xenosamide differ from other sodium channel blockers in terms of metabolism?

    -Xenosamide is unique because it is not metabolized by any microorganismal enzymes, unlike first-line sodium channel blockers such as phenytoin or carbamazepine, which means there is no drug interaction with xenosamide.

  • What is the dual mechanism of action of lacosamide?

    -Lacosamide has a dual mechanism of action: it inhibits sodium channels and also inhibits collapsing receptor-mediated protein, which is responsible for the regulation of neurotransmitter release.

  • What are the side effects of gizagobin, a potassium channel opener?

    -Gizagobin can cause physical side effects such as visual disturbances, retinal deposits, and blue pigmentation of nails and lips.

  • How does felbamate differ from other drugs in its class in terms of mechanism of action?

    -Felbamate acts as an NMDA antagonist and also blocks voltage-gated calcium channels, which is different from other drugs in its class that may target different receptors or mechanisms.

  • What are the potential serious side effects of felbamate?

    -Felbamate has potential serious side effects including bone marrow suppression and hepatotoxicity.

  • What is the mechanism of action of perampanel, an AMPA antagonist?

    -Perampanel blocks AMPA receptors, which is different from NMDA antagonists, and it is used in treating partial seizures.

  • What is the unique mechanism of action of levetiracetam?

    -Levetiracetam modulates the effect through synaptic vascular proteins, balancing the excitatory and inhibitory neurotransmitters by binding to these proteins.

  • Why is levetiracetam preferred in epilepsy treatment during pregnancy?

    -Levetiracetam is preferred in epilepsy treatment during pregnancy due to its improved efficacy and fewer adverse effects compared to other drugs, making it a first-line drug option.

Outlines

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Mindmap

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Keywords

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Highlights

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Transcripts

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now
Rate This
★
★
★
★
★

5.0 / 5 (0 votes)

Related Tags
Anti-Epileptic DrugsNeurologyPharmacologySeizure TreatmentDrug MechanismsEpilepsy CareMedical EducationNeurotransmittersDrug Side EffectsTherapeutic Advances